VC Directory

Updated 22h ago

11,013 venture capitalists profiled

Showing 2,581-2,640 of 11,013

Compare VCs →

Dr. Friederike Hoffmann

Partner

80%
b2venture

Check: b2venture does not publish a standard current check-size range on its official site.

Be the first institutional backer of outstanding European entrepreneurs and add specialist support through an experienced angel community.

Pre-SeedSeedEarly StageTechnologyEnterprise SoftwareConsumer TechnologyHealthcare

Dr. Graham Davies

Fund Principal

80%
Mercia Ventures

Check: Mercia Ventures does not publish a single standard check-size range across its managed funds.

Dr. Graham Davies invests or supports investment decisions through Mercia Ventures's published strategy: Invest across the United Kingdom in ambitious technology and life-science companies, supporting founders from first conversation through scale and exit.

SeedSeries ASeries BSoftwareDeep TechLife SciencesHealthcare

Dr. Greg Burrell

Venture Partner

80%
Necessary Ventures

Check: $1M-$2M when leading pre-seed rounds; the firm also participates from pre-seed through pre-IPO.

Dr. Greg Burrell invests or supports investments through Necessary Ventures's published strategy: Back ambitious founders across deep tech, hard tech and AI who address fundamental needs in healthcare, reindustrialization, climate, finance and education.

Pre-SeedSeedEarly StageDeep TechHealthcareClimate TechIndustrial Technology

Dr. h.c. Beate Heraeus

Strategic Advisor

80%
AENU

Check: AENU does not publish one standard current check-size range on its official site.

Dr. h.c. Beate Heraeus supports AENU, whose published strategy is: Back ambitious European founders using market-driven technology to decarbonize industry, restore ecosystems and advance climate capitalism.

SeedSeries AEarly StageClimate TechEnergyIndustrial TechnologyFood and Agriculture

Dr. Hans-Christoph Quelle

Venture Partner

80%
eCAPITAL

Check: €2M-€6M initially and up to €25M per company, as published by eCAPITAL.

Dr. Hans-Christoph Quelle invests or supports investments through eCAPITAL's published strategy: Back European deep-tech companies from seed through Series B in cybersecurity, AI infrastructure, climate, materials and semiconductors.

SeedSeries ASeries BDeep TechCybersecurityArtificial IntelligenceClimate Tech

Dr. Hanspeter Fässler

Advisory Board

80%
Spicehaus Partners

Check: Spicehaus Partners does not publish a standard current check-size range on its official site.

Dr. Hanspeter Fässler is listed in a Advisory Board capacity at Spicehaus Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

SeedEarly StageEnterprise SoftwareB2BDeep TechIndustrial Technology

Dr. Harald Nieder

General Partner

80%
redalpine

Check: redalpine does not publish a standard person-specific check-size range on its current site.

The official roster identifies Dr. Harald Nieder as General Partner. This profile applies redalpine's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Advise investments in European game changers where software and science combine to create technical breakthroughs, meaningful societal value and durable companies.

SeedSeries AGrowth StageDeep TechSoftwareLife SciencesHealth

Dr. Heinrich Baumann

Board Member

80%
Backbone Ventures

Check: Backbone Ventures does not publish a standard current check-size range on its official site.

Back exceptional and overlooked founders in Switzerland and Germany at the earliest stages with hands-on partnership.

Pre-SeedSeedEarly StageTechnologyEnterprise SoftwareDeep TechSector Agnostic

Dr. Holger Schlageter

Venture Partner

80%
Sunfish Partners

Check: €150K-€300K pre-seed tickets, as published by Sunfish Partners.

Dr. Holger Schlageter invests or supports investment decisions through Sunfish Partners's published strategy: Back Central and Eastern European founders building hardware and software for space, defence and European technological autonomy.

Pre-SeedSpace TechnologyDefense TechnologyCybersecurityRobotics

Dr. Ingo Potthof

Managing Partner

80%
UVC Partners

Check: Up to €10M initially, as published by UVC Partners.

Dr. Ingo Potthof invests or supports investments through UVC Partners's published strategy: Back ambitious European B2B technology founders in software, AI, deep tech, climate tech, mobility, and industrial transformation, with access to the UnternehmerTUM ecosystem.

Pre-SeedSeedSeries AB2B SoftwareArtificial IntelligenceDeep TechClimate Tech

Dr. Isabella Fandrych

General Partner

80%
Nucleus Capital

Check: Up to €1M initially, as published by Nucleus Capital.

Dr. Isabella Fandrych invests through Nucleus Capital's published strategy: Write first checks into European and US founders applying programmable biology and deep technology to food, materials and neo-industrial systems.

Pre-SeedSeedBiotechnologyFood TechIndustrial TechnologyClimate Tech

Dr. Isabelle Canu

Venture Circle Member

80%
NRW.Venture

Check: Up to €15M across financing rounds; EU Tech&Scale can provide up to €30M for eligible scale-ups.

Dr. Isabelle Canu is listed in a Venture Circle Member capacity at NRW.Venture. No person-specific investment authority is inferred; the firm's mandate is included only as organizational context.

SeedSeries AGrowthClimate TechArtificial IntelligenceEnterprise SoftwareCybersecurity

Dr. Ivonn Szeverenyi

Advisory Board

80%
Vespucci Partners

Check: €600K-€4.5M per company, as published by Vespucci Partners.

Back Central European teams with proprietary technology, real customer need and a credible path to international expansion.

SeedSeries ATechnologyEnterprise SoftwareArtificial IntelligenceDeep Tech

Dr. Jan Blochwitz-Nimoth

Venture Partner

80%
eCAPITAL

Check: €2M-€6M initially and up to €25M per company, as published by eCAPITAL.

Dr. Jan Blochwitz-Nimoth invests or supports investments through eCAPITAL's published strategy: Back European deep-tech companies from seed through Series B in cybersecurity, AI infrastructure, climate, materials and semiconductors.

SeedSeries ASeries BDeep TechCybersecurityArtificial IntelligenceClimate Tech

Dr. Jan Claudio Muñoz

Partner

80%
Backbone Ventures

Check: Backbone Ventures does not publish a standard current check-size range on its official site.

Back exceptional and overlooked founders in Switzerland and Germany at the earliest stages with hands-on partnership.

Pre-SeedSeedEarly StageTechnologyEnterprise SoftwareDeep TechSector Agnostic

Dr. Jan Wurzbacher

Advisor

80%
Übermorgen Ventures

Check: Übermorgen Ventures does not publish a standard current check-size range on its official site.

Dr. Jan Wurzbacher supports Übermorgen Ventures, whose published strategy is: Back early-stage European climate founders building a resilient, zero-carbon economy, with a core team supported by mission-aligned operators and scientific advisors.

Pre-SeedSeedEarly StageClimate TechEnergyFood and AgricultureIndustrial Technology

Dr. Jesko Petersen

Legal Counsel

80%
seed + speed Ventures

Check: Approximately €1M initial investment, as published by seed + speed Ventures.

Dr. Jesko Petersen is listed in a Legal Counsel capacity at seed + speed Ventures. No person-specific investment authority is inferred; the firm's mandate is included only as organizational context.

Pre-SeedSeedEnterprise SoftwareB2B SaaSArtificial IntelligenceTechnology

Dr. Jill Buban

Advisory Board Member

80%
GSV Ventures

Check: GSV Ventures does not publish a standard current check-size range on its official site.

Dr. Jill Buban is listed in a Advisory Board Member capacity at GSV Ventures. This profile preserves that role distinction and uses the firm's mandate only as shared context.

SeedSeries AGrowthEducationFuture of WorkArtificial IntelligenceConsumer Technology

Dr. Johannes Fischer

Managing Partner

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Johannes Fischer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Karin Lenzlinger Diedenhofen

Advisor

80%
Übermorgen Ventures

Check: Übermorgen Ventures does not publish a standard current check-size range on its official site.

Dr. Karin Lenzlinger Diedenhofen supports Übermorgen Ventures, whose published strategy is: Back early-stage European climate founders building a resilient, zero-carbon economy, with a core team supported by mission-aligned operators and scientific advisors.

Pre-SeedSeedEarly StageClimate TechEnergyFood and AgricultureIndustrial Technology

Dr. Karl Muth

Venture Advisor

80%
Overlook Ventures

Check: $100K-$1M initial checks, as published by Overlook Ventures.

Dr. Karl Muth is listed in a Venture Advisor capacity at Overlook Ventures. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Pre-SeedSeedInsurtechCybersecurityArtificial IntelligenceAutonomous Systems

Dr. Lan Xuezhao

Founder & Partner

80%
Basis Set Ventures

Check: $1M-$3M is common, with published checks ranging from a few hundred thousand dollars to more than $9M.

Dr. Lan Xuezhao invests or supports investments through Basis Set Ventures's published strategy: Partner from pre-seed through Series A with AI-native founders building software and infrastructure that scale human capability and reshape work.

Pre-SeedSeedSeries AArtificial IntelligenceEnterprise SoftwareDeveloper ToolsAutomation

Dr. Lauren Lentz

General Partner

80%
Revent

Check: €1M-€3M initial investments, as published by Revent.

Dr. Lauren Lentz invests or supports investment decisions through Revent's published strategy: Back mission-driven founders at day zero applying technology to planetary and societal challenges, human flourishing and AI for society.

Pre-SeedSeedClimate TechHealthcareDeep TechArtificial Intelligence

Dr. Lisa Gartenmann

Manager

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Lisa Gartenmann invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Lisa Hehenberger

Impact & Advisory Board Member

80%
Rubio Impact Ventures

Check: Rubio Impact Ventures does not publish one standard current check-size range on its official site.

Dr. Lisa Hehenberger supports Rubio Impact Ventures, whose published strategy is: Back scalable European companies across People Power and Planet Paradise themes, combining venture returns with measurable social or environmental impact.

SeedSeries AGrowthClimate TechFood TechHealthcareFuture of Work

Dr. Louis-Paul Wicki

Industry Network - IT

80%
EquityPitcher Ventures

Check: EquityPitcher Ventures does not publish a standard current check-size range on its official site.

Dr. Louis-Paul Wicki is listed in a Industry Network - IT capacity at EquityPitcher Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly StageTechnologyEnterprise SoftwareFintechDigital Health

Dr. Luca Del Medico

Associate

80%
redalpine

Check: redalpine does not publish a standard person-specific check-size range on its current site.

The official roster identifies Dr. Luca Del Medico as Associate. This profile applies redalpine's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Advise investments in European game changers where software and science combine to create technical breakthroughs, meaningful societal value and durable companies.

SeedSeries AGrowth StageDeep TechSoftwareLife SciencesHealth

Dr. Lucas Mittelmeier

Investment Team

80%
Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Dr. Lucas Mittelmeier.

Dr. Lucas Mittelmeier works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth StageHealthTechDigital HealthHealthcareLife Sciences

Dr. Manu Kumar

Chief Firestarter

80%
K9 Ventures

Check: $250K-$750K initial investments, with a published sweet spot around $400K.

Dr. Manu Kumar invests or supports investments through K9 Ventures's published strategy: Be the first professional investor in Bay Area technology startups led by technical founders creating a new technology or market.

Pre-SeedSeedTechnologyEnterprise SoftwareDeveloper ToolsArtificial Intelligence

Dr. Marc Moesser

Partner

80%
redalpine

Check: redalpine does not publish a standard person-specific check-size range on its current site.

The official roster identifies Dr. Marc Moesser as Partner. This profile applies redalpine's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Advise investments in European game changers where software and science combine to create technical breakthroughs, meaningful societal value and durable companies.

SeedSeries AGrowth StageDeep TechSoftwareLife SciencesHealth

Dr. Marcus Erken

Co-Founder and Managing Partner

80%
Sunfish Partners

Check: €150K-€300K pre-seed tickets, as published by Sunfish Partners.

Dr. Marcus Erken invests or supports investment decisions through Sunfish Partners's published strategy: Back Central and Eastern European founders building hardware and software for space, defence and European technological autonomy.

Pre-SeedSpace TechnologyDefense TechnologyCybersecurityRobotics

Dr. Marek Kozlowski

Senior Investment Director, Life Science & CleanTech

80%
NRW.Venture

Check: Up to €15M across financing rounds; EU Tech&Scale can provide up to €30M for eligible scale-ups.

Dr. Marek Kozlowski invests or supports investment decisions through NRW.Venture's published strategy: Co-invest in innovative NRW companies that have completed seed, angel or initial VC financing across technology, life sciences, climate and digital markets.

SeedSeries AGrowthClimate TechArtificial IntelligenceEnterprise SoftwareCybersecurity

Dr. Maria Bräutigam

Investment Manager, Life Science & Cleantech

80%
NRW.Venture

Check: Up to €15M across financing rounds; EU Tech&Scale can provide up to €30M for eligible scale-ups.

Dr. Maria Bräutigam invests or supports investment decisions through NRW.Venture's published strategy: Co-invest in innovative NRW companies that have completed seed, angel or initial VC financing across technology, life sciences, climate and digital markets.

SeedSeries AGrowthClimate TechArtificial IntelligenceEnterprise SoftwareCybersecurity

Dr. Mark Windeknecht

Principal

80%
World Fund

Check: World Fund does not publish one standard check-size range on its current official site.

Dr. Mark Windeknecht invests through World Fund's published strategy: Back European climate technologies in energy, industry, and food and agriculture that have material emissions-reduction potential and venture-scale economics.

Pre-SeedSeedSeries AClimate TechEnergyIndustrial TechnologyFood and Agriculture

Dr. Markus Müschenich

Founding Partner

80%
Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Dr. Markus Müschenich.

Dr. Markus Müschenich works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth StageHealthTechDigital HealthHealthcareLife Sciences

Dr. Markus Wiedenmann

Investment Advisory Board Member

80%
Realyze Ventures

Check: €500K-€3M initial investments, as published by Realyze Ventures.

Dr. Markus Wiedenmann is listed in a Investment Advisory Board Member capacity at Realyze Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedSeries AConstruction TechReal Estate TechClimate TechEnergy

Dr. Mazen Rizk

Scientific Advisor

80%
Nucleus Capital

Check: Up to €1M initially, as published by Nucleus Capital.

Dr. Mazen Rizk supports Nucleus Capital, whose published strategy is: Write first checks into European and US founders applying programmable biology and deep technology to food, materials and neo-industrial systems.

Pre-SeedSeedBiotechnologyFood TechIndustrial TechnologyClimate Tech

Dr. Mel Spigelman

Venture Partner

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Mel Spigelman invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Michael Sidler

Founding Partner

80%
redalpine

Check: redalpine does not publish a standard person-specific check-size range on its current site.

The official roster identifies Dr. Michael Sidler as Founding Partner. This profile applies redalpine's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Advise investments in European game changers where software and science combine to create technical breakthroughs, meaningful societal value and durable companies.

SeedSeries AGrowth StageDeep TechSoftwareLife SciencesHealth

Dr. Moritz Beissenhirtz

Investment Director, Life Sciences

80%
Brandenburg Kapital

Check: Brandenburg Kapital does not publish one standard check-size range on its current site.. No person-specific check range is inferred for Dr. Moritz Beissenhirtz.

Dr. Moritz Beissenhirtz works on Brandenburg Kapital's strategy to provide venture and mezzanine capital plus long-term strategic support to dynamic startups and SMEs creating technology-led growth in Brandenburg. The firm does not publish a narrower personal mandate on the cited roster.

StartupEarly StageGrowth StageInformation TechnologyIndustrial TechnologyLife SciencesHealthcare

Dr. Nachi Gupta

Venture Partner and Technical Advisor

80%
Necessary Ventures

Check: $1M-$2M when leading pre-seed rounds; the firm also participates from pre-seed through pre-IPO.

Dr. Nachi Gupta is listed in a Venture Partner and Technical Advisor capacity at Necessary Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly StageDeep TechHealthcareClimate TechIndustrial Technology

Dr. Nathalie Weitemeyer

Director, Life Science and Senior Investment Manager

80%
Bayern Kapital

Check: €250K-€50M across stages, as published in Bayern Kapital's official investment criteria.

Dr. Nathalie Weitemeyer invests or supports investment decisions through Bayern Kapital's published strategy: Co-invest as a long-term anchor from pre-seed through growth in scalable high-tech and deep-tech companies with a registered office or operating site in Bavaria.

Pre-SeedSeedSeries ADeep TechArtificial IntelligenceEnterprise SoftwareLife Sciences

Dr. Nikolaus Raupp

Partner

80%
DeepTech & Climate Fonds

Check: €5M-€10M initial-investment sweet spot and up to €50M per company, as published by DTCF.

Dr. Nikolaus Raupp invests or supports investment decisions through DeepTech & Climate Fonds's published strategy: Back Germany-based or Germany-affiliated technology companies with long development cycles, strong scientific or engineering foundations and the potential to become globally competitive technology leaders.

Series AEarly GrowthGrowth StageDeep TechClimate TechIndustrial TechnologyAdvanced Computing

Dr. Nils Eiteneyer

Partner

80%
Capnamic

Check: Capnamic does not publish a single standard check-size range on its current official site.

Dr. Nils Eiteneyer invests or supports investment decisions through Capnamic's published strategy: Partner early with outstanding European technology founders building category-defining companies across software, deep tech and digitally enabled markets.

Pre-SeedSeedSeries AEnterprise SoftwareArtificial IntelligenceDeep TechFintech

Dr. Ole Wiesinger

Industry Network - Digital Health

80%
EquityPitcher Ventures

Check: EquityPitcher Ventures does not publish a standard current check-size range on its official site.

Dr. Ole Wiesinger is listed in a Industry Network - Digital Health capacity at EquityPitcher Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly StageTechnologyEnterprise SoftwareFintechDigital Health

Dr. Oliver Pabst

General Partner

80%
redalpine

Check: redalpine does not publish a standard person-specific check-size range on its current site.

The official roster identifies Dr. Oliver Pabst as General Partner. This profile applies redalpine's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Advise investments in European game changers where software and science combine to create technical breakthroughs, meaningful societal value and durable companies.

SeedSeries AGrowth StageDeep TechSoftwareLife SciencesHealth

Dr. Oliver Schoppe

Partner

80%
UVC Partners

Check: Up to €10M initially, as published by UVC Partners.

Dr. Oliver Schoppe invests or supports investments through UVC Partners's published strategy: Back ambitious European B2B technology founders in software, AI, deep tech, climate tech, mobility, and industrial transformation, with access to the UnternehmerTUM ecosystem.

Pre-SeedSeedSeries AB2B SoftwareArtificial IntelligenceDeep TechClimate Tech

Dr. Patricia Bubner

Scientific Advisor

80%
Nucleus Capital

Check: Up to €1M initially, as published by Nucleus Capital.

Dr. Patricia Bubner supports Nucleus Capital, whose published strategy is: Write first checks into European and US founders applying programmable biology and deep technology to food, materials and neo-industrial systems.

Pre-SeedSeedBiotechnologyFood TechIndustrial TechnologyClimate Tech

Dr. Patrick Mollet

Advisory Board

80%
Spicehaus Partners

Check: Spicehaus Partners does not publish a standard current check-size range on its official site.

Dr. Patrick Mollet is listed in a Advisory Board capacity at Spicehaus Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

SeedEarly StageEnterprise SoftwareB2BDeep TechIndustrial Technology

Dr. Paul Campbell

Managing Partner

80%
Brown Venture Group

Check: Not publicly specified on the official site

At the firm level, Brown Venture Group backs undervalued and under-resourced Black, Latino, and Indigenous technology founders building scalable companies.

Early stageTechnology companies led by BlackLatinoIndigenous founders

Dr. Paul Grunow

Venture Partner

80%
eCAPITAL

Check: €2M-€6M initially and up to €25M per company, as published by eCAPITAL.

Dr. Paul Grunow invests or supports investments through eCAPITAL's published strategy: Back European deep-tech companies from seed through Series B in cybersecurity, AI infrastructure, climate, materials and semiconductors.

SeedSeries ASeries BDeep TechCybersecurityArtificial IntelligenceClimate Tech

Dr. Peter Hirth

Venture Partner

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Peter Hirth invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Petrissa Eckle

Advisor

80%
Übermorgen Ventures

Check: Übermorgen Ventures does not publish a standard current check-size range on its official site.

Dr. Petrissa Eckle supports Übermorgen Ventures, whose published strategy is: Back early-stage European climate founders building a resilient, zero-carbon economy, with a core team supported by mission-aligned operators and scientific advisors.

Pre-SeedSeedEarly StageClimate TechEnergyFood and AgricultureIndustrial Technology

Dr. Rainer Strohmenger

Managing Partner

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Rainer Strohmenger invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Raymond Levitt

Senior Advisor

80%
Blackhorn Ventures

Check: Blackhorn Ventures does not publish a standard current check-size range on its official site.

Dr. Raymond Levitt is listed in a Senior Advisor capacity at Blackhorn Ventures. This profile preserves that role distinction and uses the firm's mandate only as shared context.

SeedSeries AClimate TechIndustrial TechnologyEnergyConstruction

Dr. Regina Hodits

Venture Advisor

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Regina Hodits is listed in a Venture Advisor capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Robert Buschauer

Associate

80%
Wellington Partners

Check: €2M-€20M initial investments, as published by Wellington Partners.

Dr. Robert Buschauer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.

Early StageGrowthLife SciencesBiotechnologyTherapeuticsMedical Devices

Dr. Robert Hornby

Investor

80%
Mercia Ventures

Check: Mercia Ventures does not publish a single standard check-size range across its managed funds.

Dr. Robert Hornby invests or supports investment decisions through Mercia Ventures's published strategy: Invest across the United Kingdom in ambitious technology and life-science companies, supporting founders from first conversation through scale and exit.

SeedSeries ASeries BSoftwareDeep TechLife SciencesHealthcare

Dr. Sarah Theinert

Director Value Creation

80%
UVC Partners

Check: Up to €10M initially, as published by UVC Partners.

Dr. Sarah Theinert is listed in a Director Value Creation capacity at UVC Partners. The firm does not publish a person-specific investment thesis for this role; this profile preserves the role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedSeries AB2B SoftwareArtificial IntelligenceDeep TechClimate Tech

Dr. Scott C. Hsu

Fusion Partner

80%
Lowercarbon Capital

Check: Lowercarbon Capital does not publish a standard current check-size range on its official site.

Dr. Scott C. Hsu invests or supports investments through Lowercarbon Capital's published strategy: Invest in companies capable of making real progress on climate by slashing emissions, removing carbon and advancing transformational energy systems.

Pre-SeedSeedSeries AClimate TechEnergyCarbon RemovalFusion

Stay in the loop

Get a weekly digest of VC insights, new profiles, and funding rounds.